Long non-coding RNA SNHG6 promotes the growth and invasion of non-small cell lung cancer by downregulating miR-101-3p

被引:17
作者
Li, Ke [1 ]
Jiang, Yongxin [2 ]
Xiang, Xudong [3 ]
Gong, Quan [4 ]
Zhou, Chunyan [4 ]
Zhang, Lijuan [4 ]
Ma, Qianli [3 ]
Zhuang, Li [4 ]
机构
[1] Kunming Med Univ, Yunnan Canc Hosp, Canc Biotherapy Ctr, Affiliated Hosp 3, Kunming, Yunnan, Peoples R China
[2] Kunming Med Univ, Yunnan Canc Hosp, Canc Inst, Affiliated Hosp 3, Kunming, Yunnan, Peoples R China
[3] Kunming Med Univ, Yunnan Canc Hosp, Chorac Surg, Affiliated Hosp 3, Kunming, Yunnan, Peoples R China
[4] Kunming Med Univ, Yunnan Canc Hosp, Dept Palliat Med, Affiliated Hosp 3, 519 Kunzhou Rd, Kunming 650118, Yunnan, Peoples R China
关键词
Growth; invasion; miR-101-3p; non-small cell lung cancer; SNHG6; COMPETING ENDOGENOUS RNA; PROLIFERATION; CARCINOMA; SENSITIVITY; METASTASIS; EXPRESSION; PATHWAY; EMT;
D O I
10.1111/1759-7714.13371
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The aim of this study was to determine the function of long non-coding RNA small nucleolar RNA host gene 6 (SNHG6) in non-small cell lung cancer (NSCLC) and its underlying mechanisms. Methods The association of SNHG6 or miR-101-3p with clinicopathological characteristics and prognosis in patents with NSCLC was assessed by TCGA dataset. Cell proliferation and invasion were evaluated by MTT and Transwell assays and SNHG6-specific binding with miR-101-3p was verified by bioinformatic analysis, luciferase gene report and RNA immunoprecipitation assays. qRT-PCR and Western blot was used to assess the effects of SNHG6 on the expression of miR-101-3p and chromodomain Y like (CDYL) in NSCLC cells. A xenograft tumor model in vivo was established to observe the effects of SNHG6 knockdown on tumor growth. Results We found that increased expression of SNHG6 was associated with pathological stage and lymph node infiltration, and acted as an independent prognostic factor of tumor recurrence in patients with NSCLC. Silencing SNHG6 expression repressed cell growth and invasion in vitro and in vivo, but overexpression of SNHG6 reversed these effects. Furthermore, SNHG6 was identified to act as a sponge of miR-101-3p, which could reduce cell proliferation and attenuate SNHG6-induced CDYL expression. Low expression of miR-101-3p or high expression of CDYL was related to poor survival in patients with NSCLC. Conclusions Our findings demonstrated that lncRNA SNHG6 contributed to the proliferation and invasion of NSCLC by downregulating miR-101-3p.
引用
收藏
页码:1180 / 1190
页数:11
相关论文
共 26 条
  • [1] The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma
    Cao, C.
    Zhang, T.
    Zhang, D.
    Xie, L.
    Zou, X.
    Lei, L.
    Wu, D.
    Liu, L.
    [J]. ONCOGENE, 2017, 36 (08) : 1112 - 1122
  • [2] LINC01303 functions as a competing endogenous RNA to regulate EZH2 expression by sponging miR-101-3p in gastric cancer
    Cao, Chen
    Xu, Ying
    Du, Ke
    Mi, Chenyang
    Yang, Chuanhua
    Xiang, Lili
    Xie, Yan
    Liu, Wenneng
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (11) : 7342 - 7348
  • [3] lncRNA SPRY4-IT1 Regulates Cell Proliferation and Migration by Sponging miR-101-3p and Regulating AMPK Expression in Gastric Cancer
    Cao, Shuguang
    Lin, Limiao
    Xia, Xuanping
    Wu, Hao
    [J]. MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 17 : 455 - 464
  • [4] Cancer incidence and mortality in China, 2013
    Chen, Wanqing
    Zheng, Rongshou
    Zhang, Siwei
    Zeng, Hongmei
    Xia, Changfa
    Zuo, Tingting
    Yang, Zhixun
    Zou, Xiaonong
    He, Jie
    [J]. CANCER LETTERS, 2017, 401 : 63 - 71
  • [5] LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway
    Huang, Yanxia
    Zhang, Jing
    Hou, Lidan
    Wang, Ge
    Liu, Hui
    Zhang, Rui
    Chen, Xiaoyu
    Zhu, Jinshui
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [6] SNHG6 is upregulated in primary breast cancers and promotes cell cycle progression in breast cancer-derived cell lines
    Jafari-Oliayi, Amin
    Asadi, Malek Hossein
    [J]. CELLULAR ONCOLOGY, 2019, 42 (02) : 211 - 221
  • [7] MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2
    Li, Bo
    Xie, Dalong
    Zhang, Hui
    [J]. JOURNAL OF CANCER, 2019, 10 (12): : 2628 - 2634
  • [8] MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44
    Li, Ling
    Shao, Mei-Ying
    Zou, Shu-Cheng
    Xiao, Zhe-Feng
    Chen, Zhu-Chu
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2019, 141 (01) : 19 - 30
  • [9] Long noncoding RNA SNHG6 regulates p21 expression via activation of the JNK pathway and regulation of EZH2 in gastric cancer cells
    Li, Yan
    Li, Dongdong
    Zhao, Mei
    Huang, Shengkai
    Zhang, Qiao
    Lin, Hong
    Wang, Wenjie
    Li, Kexin
    Li, Zihao
    Huang, Weiyan
    Che, Yiqun
    Huang, Changzhi
    [J]. LIFE SCIENCES, 2018, 208 : 295 - 304
  • [10] LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression
    Liang, Haihai
    Yu, Tong
    Han, Yue
    Jiang, Hua
    Wang, Chengyu
    You, Tianyi
    Zhao, Xiaoguang
    Shan, Huitong
    Yang, Rui
    Yang, Lida
    Shan, Hongli
    Gu, Yunyan
    [J]. MOLECULAR CANCER, 2018, 17